Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Receivables (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Receivables for 10 consecutive years, with $5.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables rose 5.27% to $5.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.5 million, a 5.27% increase, with the full-year FY2024 number at $6.0 million, up 47.22% from a year prior.
  • Receivables was $5.5 million for Q3 2025 at KORU Medical Systems, up from $5.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $6.3 million in Q1 2025 to a low of $31489.0 in Q4 2023.
  • A 5-year average of $4.1 million and a median of $4.7 million in 2024 define the central range for Receivables.
  • Peak YoY movement for Receivables: crashed 99.01% in 2023, then skyrocketed 18947.74% in 2024.
  • KORU Medical Systems' Receivables stood at $4.3 million in 2021, then fell by 26.41% to $3.2 million in 2022, then plummeted by 99.01% to $31489.0 in 2023, then surged by 18947.74% to $6.0 million in 2024, then dropped by 8.05% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Receivables are $5.5 million (Q3 2025), $5.1 million (Q2 2025), and $6.3 million (Q1 2025).